Immediate Impact
2 from Science/Nature 50 standout
Citing Papers
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
Biomaterials technology and policies in the building sector: a review
2024 Standout
Works of Melissa Johnson being referenced
Abstract CT224: Phase Ib/II, open label, multicenter study of inhaled DV281, a Toll-like receptor 9 agonist, in combination with nivolumab in patients with advanced or metastatic non small cell lung cancer (NSCLC)
2019
Influence of moisture on the mechanical behavior of a natural composite
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Melissa Johnson | 34 | 20 | 56 | 26 | 26 | 212 | |
| Huan Deng | 38 | 50 | 22 | 35 | 40 | 286 | |
| Yingyan Zheng | 24 | 23 | 35 | 29 | 30 | 276 | |
| Max Wacker | 32 | 29 | 35 | 88 | 30 | 257 | |
| Fabienne Jordana | 13 | 38 | 36 | 33 | 22 | 291 | |
| Jinxing Hu | 11 | 58 | 41 | 40 | 18 | 241 | |
| Hesham Mohammed Al‐Sharani | 13 | 51 | 45 | 53 | 27 | 224 | |
| Kevin Sheng-Kai | 31 | 20 | 34 | 31 | 20 | 236 | |
| Verónica Sánchez‐López | 16 | 64 | 77 | 35 | 29 | 241 | |
| Weili Du | 21 | 71 | 23 | 72 | 35 | 273 | |
| Víctor Hugo Toral-Rizo | 43 | 27 | 18 | 44 | 28 | 253 |
All Works
Login with ORCID to disown or claim papers
Loading papers...